Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: A report from the International Neuroblastoma Risk Group project

Journal of Clinical Oncology

Volumn 32, Issue 28, 2014, Pages 3169-3176

  Vo, Kieuhoa T ^a   Matthay, Katherine K ^a   Neuhaus, John ^a   London, Wendy B ^c   Hero, Barbara ^d   Ambros, Peter F ^e   Nakagawara, Akira ^f   Miniati, Doug ^b   Wheeler, Kate ^g   Pearson, Andrew D J ^h   Cohn, Susan L ⁱ   DuBois, Steven G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF COLOGNE   (Germany)

^e CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^f CHIBA UNIVERSITY   (Japan)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; LACTATE DEHYDROGENASE; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ADOLESCENT; ADRENAL TUMOR; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CHILD; CHROMOSOME ABERRATION; CLINICAL FEATURE; EVENT FREE SURVIVAL; FERRITIN BLOOD LEVEL; GENE; GENE AMPLIFICATION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MYCN GENE; NEUROBLASTOMA; OVERALL SURVIVAL; PRIMARY TUMOR; THORAX TUMOR; TUMOR LOCALIZATION; CANCER STAGING; FACTUAL DATABASE; GENETICS; HEAD AND NECK TUMOR; INFANT; INTERNATIONAL COOPERATION; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY; PELVIS TUMOR; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADRENAL GLAND NEOPLASMS; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; DATABASES, FACTUAL; FERRITINS; GENE AMPLIFICATION; HEAD AND NECK NEOPLASMS; HUMANS; INFANT; INTERNATIONAL COOPERATION; KAPLAN-MEIER ESTIMATE; L-LACTATE DEHYDROGENASE; LOGISTIC MODELS; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PELVIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; THORACIC NEOPLASMS;

EID: 84907582413     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.1621     Document Type: Article

References (24)

1. Carlsen NL, Christensen IJ, Schroeder H, et al: Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980: A statistical estimate of prognosis based 253 cases. Cancer 58:2726-2735, 1986
2. Oppedal BR, Storm-Mathisen I, Lie SO, et al: Prognostic factors in neuroblastoma: Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer 62:772-780, 1988
3. Joshi VV, Cantor AB, Altshuler G, et al: Recommendations for modifications of terminology of neuroblastic tumors and prognostic significance of Shimada classification: A clinicopathologic study of 213 cases from the Pediatric Oncology Group. Cancer 69:2183-2196, 1992
4. Sung KW, Yoo KH, Koo HH, et al: Neuroblastoma originating from extra-abdominal sites: Association with favorable clinical and biological features. J Korean Med Sci 24:461-467, 2009
5. Ladenstein R, Urban C, Gadner H, et al: First experience with prognostic factors in unselected neuroblastoma patients: The Austrian Neuroblastoma 87 study. Eur J Cancer 31A:637-641, 1995
6. Haase GM, O'Leary MC, Stram DO, et al: Pelvic neuroblastoma: Implications for a new favorable subgroup: A Children's Cancer Group experience. Ann Surg Oncol 2:516-523, 1995
7. Leclair MD, Hartmann O, Heloury Y, et al: Localized pelvic neuroblastoma: Excellent survival and low morbidity with tailored therapy-The 10- year experience of the French Society of Pediatric Oncology. J Clin Oncol 22:1689-1695, 2004
8. Adams GA, Shochat SJ, Smith EI, et al: Thoracic neuroblastoma: A Pediatric Oncology Group study. J Pediatr Surg 28:372-378, 1993
9. Caron HN: Are thoracic neuroblastomas really different? Pediatr Blood Cancer 54:867, 2010
10. Cohn SL, Pearson AD, London WB, et al: The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report. J Clin Oncol 27:289-297, 2009
11. Shimada H, Ambros IM, Dehner LP, et al: Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee. Cancer 86:349-363, 1999
12. Ambros PF, Ambros IM, Brodeur GM, et al: International consensus for neuroblastoma moleculardiagnostics: Report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 100:1471-1482, 2009
13. Schleiermacher G, Mosseri V, London WB, et al: Segmental chromosomal alterations have prognostic impact in neuroblastoma: A report from the INRG project. Br J Cancer 107:1418-1422, 2012
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Häberle B, Hero B, Berthold F, et al: Characteristics and outcome of thoracic neuroblastoma. Eur J Pediatr Surg 12:145-150, 2002
16. Morris JA, Shcochat SJ, Smith EI, et al: Biological variables in thoracic neuroblastoma:APediatric Oncology Group Study. J Pediatr Surg 30:296-303, 1995
17. Schilling FH, Spix C, Berthold F, et al: Neuroblastoma screening at one year of age. N Engl J Med 346:1047-1053, 2002
18. Tanaka M, Kigasawa H, Kato K, et al: A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening. Pediatr Blood Cancer 54:573-578, 2010
19. Qureshi SS, Kembhavi S, Ramadwar M, et al: Outcome and morbidity of surgical resection of primary cervical and cervicothoracic neuroblastoma in children: A comparative analysis. Pediatr Surg Int 30:267-273, 2014
20. Abramson SJ, Berdon WE, Ruzal-Shapiro C, et al: Cervical neuroblastoma in eleven infants: A tumor with favorable prognosis-Clinical and radiologic (US, CT, MRI) findings. Pediatr Radiol 23:253-257, 1993
21. Demir HA, Yalçin B, Büyükpamukçu N, et al: Thoracic neuroblastic tumors in childhood. Pediatr Blood Cancer 54:885-889, 2010
22. Matthay KK, Sather HN, Seeger RC, et al: Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236-244, 1989
23. Cardesa-Salzmann TM, Mora-Graupera J, Claret G, et al: Congenital cervical neuroblastoma. Pediatr Blood Cancer 43:785-787, 2004
24. Haddad M, Triglia JM, Helardot P, et al: Localized cervical neuroblastoma: Prevention of surgical complications. Int J Pediatr Otorhinolaryngol 67: 1361-1367, 2003